HEALTHHealth CareMedical MysteriesScienceWell+Being
WHO approves second, affordable vaccine in fight against deadly malaria
The World Health Organization has approved a new anti-malaria vaccine, which will offer countries a cheap and more accessible option to combat one of the leading causes of child deaths in Africa.
Developed by Oxford University, the R21/Matrix-M vaccine is the second such vaccine to be recommended by the WHO
By Niha MasihNiha Masih is a reporter at The Washington Post’s Seoul hub, where she covers breaking news in the United States and across the world. Previously, she was The Post’s correspondent in India, where she covered the rise of majoritarian nationalism, conflict in Kashmir, the covid crisis and digital surveillance of citizens.
